Delirium and Delirium Severity Predict the Trajectory of the Hierarchical Assessment of Balance and Mobility in Hospitalized Older People: Findings From the DECIDE Study.

Epidemiology Hospital related Physical function

Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
03 03 2022
Historique:
received: 23 11 2020
entrez: 3 3 2022
pubmed: 4 3 2022
medline: 19 4 2022
Statut: ppublish

Résumé

Delirium is common, distressing, and associated with poor outcomes. Despite this, delirium remains poorly recognized, resulting in worse outcomes. There is an urgent need for methods to objectively assess for delirium. Physical function has been proposed as a potential surrogate marker, but few studies have monitored physical function in the context of delirium. We examined if trajectories of physical function are affected by the presence and severity of delirium in a representative sample of hospitalized participants older than 65 years. During hospital admissions in 2016, we assessed participants from the Delirium and Cognitive Impact in Dementia study daily for delirium and physical function, using the Hierarchical Assessment of Balance and Mobility (HABAM). We used linear mixed models to assess the effect of delirium and delirium severity during admission on HABAM trajectory. Of 178 participants, 58 experienced delirium during admission. Median HABAM scores in those with delirium were significantly higher (indicating worse mobility) than those without delirium. Modeling HABAM trajectories, HABAM scores at first assessment were worse in those with delirium than those without, by 0.76 (95% CI: 0.49-1.04) points. Participants with severe delirium experienced a much greater perturbance in their physical function, with an even lower value at first assessment and slower subsequent improvement. Physical function was worse in those with delirium compared to without. This supports the assertion that motor disturbances are a core feature of delirium and monitoring physical function, using a tool such as the HABAM, may have clinical utility as a surrogate marker for delirium and its resolution.

Sections du résumé

BACKGROUND
Delirium is common, distressing, and associated with poor outcomes. Despite this, delirium remains poorly recognized, resulting in worse outcomes. There is an urgent need for methods to objectively assess for delirium. Physical function has been proposed as a potential surrogate marker, but few studies have monitored physical function in the context of delirium. We examined if trajectories of physical function are affected by the presence and severity of delirium in a representative sample of hospitalized participants older than 65 years.
METHOD
During hospital admissions in 2016, we assessed participants from the Delirium and Cognitive Impact in Dementia study daily for delirium and physical function, using the Hierarchical Assessment of Balance and Mobility (HABAM). We used linear mixed models to assess the effect of delirium and delirium severity during admission on HABAM trajectory.
RESULTS
Of 178 participants, 58 experienced delirium during admission. Median HABAM scores in those with delirium were significantly higher (indicating worse mobility) than those without delirium. Modeling HABAM trajectories, HABAM scores at first assessment were worse in those with delirium than those without, by 0.76 (95% CI: 0.49-1.04) points. Participants with severe delirium experienced a much greater perturbance in their physical function, with an even lower value at first assessment and slower subsequent improvement.
CONCLUSIONS
Physical function was worse in those with delirium compared to without. This supports the assertion that motor disturbances are a core feature of delirium and monitoring physical function, using a tool such as the HABAM, may have clinical utility as a surrogate marker for delirium and its resolution.

Identifiants

pubmed: 35239950
pii: 6542027
doi: 10.1093/gerona/glab081
pmc: PMC8893191
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

531-535

Subventions

Organisme : Alzheimer's Society
ID : 239 [AS-CTF-14-001
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601022
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America.

Références

JAMA. 2010 Jul 28;304(4):443-51
pubmed: 20664045
BMC Geriatr. 2017 Apr 28;17(1):98
pubmed: 28454532
BMC Geriatr. 2019 Sep 11;19(1):253
pubmed: 31510941
Am J Geriatr Psychiatry. 2013 Dec;21(12):1244-53
pubmed: 24080383
Age Ageing. 1995 Mar;24(2):126-30
pubmed: 7793334
BMC Geriatr. 2018 Feb 9;18(1):45
pubmed: 29426299
Lancet. 2013 Oct 26;382(9902):1405-12
pubmed: 23871492
J Psychosom Res. 2012 Mar;72(3):236-41
pubmed: 22325705
Lancet. 2014 Jun 14;383(9934):2045
pubmed: 24931690
J Am Geriatr Soc. 2008 Jul;56(7):1213-7
pubmed: 18503518
J Am Med Dir Assoc. 2011 Jun;12(5):387-8; author reply 388
pubmed: 21450259
Age Ageing. 2017 Nov 1;46(6):920-925
pubmed: 28104595
J Pain Symptom Manage. 1997 Mar;13(3):128-37
pubmed: 9114631
J Clin Epidemiol. 2000 Dec;53(12):1242-7
pubmed: 11146271
CMAJ. 2005 Dec 6;173(12):1502-3
pubmed: 16330654
Psychiatry Res. 1992 Mar;41(3):237-48
pubmed: 1594710
Age Ageing. 2021 May 5;50(3):914-920
pubmed: 33320945
Int J Geriatr Psychiatry. 2018 Nov;33(11):1501-1511
pubmed: 28393426
Int Psychogeriatr. 2019 May;31(5):749-753
pubmed: 30318022
BMC Med. 2019 Dec 14;17(1):229
pubmed: 31837711

Auteurs

Sarah Richardson (S)

AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

James Murray (J)

AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

Daniel Davis (D)

MRC Unit for Lifelong Health and Ageing at UCL, London, UK.

Blossom C M Stephan (BCM)

Institute of Mental Health, Division of Psychiatry and Applied Psychology, School of Medicine, Nottingham University, UK.

Louise Robinson (L)

Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Carol Brayne (C)

Cambridge Public Health, University of Cambridge, UK.

Linda Barnes (L)

Cambridge Public Health, University of Cambridge, UK.

Stuart Parker (S)

Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Avan A Sayer (AA)

AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

Richard M Dodds (RM)

AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

Louise Allan (L)

Centre for Research in Ageing and Cognitive Health, University of Exeter, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH